Press Release:
Irish cheese and nutritional ingredients maker Glanbia (ISE:GL9) on Wednesday said it had bought US sector player Bio-Engineered Supplements and Nutrition (BSN) for USD144m (EUR107m), in line with its strategy to grow in the sports nutrition sector. Glanbia has financed the deal with existing debt facilities and expects the acquisition to increase its earnings in 2011. BSN employs 140 people and sells its products through 40,000 retail stores in the US as well as in 90 countries globally. It booked net revenues of USD135.4m and an adjusted EBIT of USD16.3m in 2009. Its gross assets stood at USD30.5m at the end of December 2009. Country: , USA Sector: Pharmaceuticals, Food/Beverages/Tobacco Target: Bio-Engineered Supplements & Nutrition Inc (BSN) Buyer: Glanbia Plc Deal size in USD: 144m Type: Corporate acquisition Financing: Existing resources, Debt Status: Closed
Glanbia buys US nutrition business BSN for USD144m | TradingMarkets.com
Irish cheese and nutritional ingredients maker Glanbia (ISE:GL9) on Wednesday said it had bought US sector player Bio-Engineered Supplements and Nutrition (BSN) for USD144m (EUR107m), in line with its strategy to grow in the sports nutrition sector. Glanbia has financed the deal with existing debt facilities and expects the acquisition to increase its earnings in 2011. BSN employs 140 people and sells its products through 40,000 retail stores in the US as well as in 90 countries globally. It booked net revenues of USD135.4m and an adjusted EBIT of USD16.3m in 2009. Its gross assets stood at USD30.5m at the end of December 2009. Country: , USA Sector: Pharmaceuticals, Food/Beverages/Tobacco Target: Bio-Engineered Supplements & Nutrition Inc (BSN) Buyer: Glanbia Plc Deal size in USD: 144m Type: Corporate acquisition Financing: Existing resources, Debt Status: Closed
Glanbia buys US nutrition business BSN for USD144m | TradingMarkets.com

Comment